Edition:
United Kingdom

Marksans Pharma Ltd (MARK.NS)

MARK.NS on National Stock Exchange of India

35.35INR
15 Dec 2017
Change (% chg)

Rs0.15 (+0.43%)
Prev Close
Rs35.20
Open
Rs35.70
Day's High
Rs36.15
Day's Low
Rs35.10
Volume
4,466,782
Avg. Vol
3,951,180
52-wk High
Rs58.25
52-wk Low
Rs35.10

Chart for

About

Marksans Pharma Limited is a pharmaceutical holding company. The Company is engaged in the research, manufacturing and marketing of generic pharmaceutical formulations. The Company's product portfolio addresses various therapeutic segments, including Pain management, Cough and cold, Anti-diabetic, Cardiovascular system, Central... (more)

Overall

Beta: 1.92
Market Cap(Mil.): Rs19,606.13
Shares Outstanding(Mil.): 409.31
Dividend: 0.05
Yield (%): 0.10

Financials

  Industry Sector
P/E (TTM): -- 31.14 16.44
EPS (TTM): -- -- --
ROI: -- 14.86 10.62
ROE: -- 16.28 14.20

BRIEF-India's Marksans Pharma Sept-qtr consol profit rises

* Sept quarter consol profit 104.1 million rupees versus profit of 7.5 million rupees year ago

13 Nov 2017

BRIEF-Marksans Pharma gets EIR from U.S. FDA for inspection of Goa facility‍​‍​

* Says got EIR from U.S. Fda for inspection of co's Goa facility

09 Oct 2017

BRIEF-India's Marksans Pharma June-qtr profit falls

* June quarter profit 11.6 million rupees versus profit 40.5 million rupees year ago

11 Aug 2017

Earnings vs. Estimates